'Grey's Anatomy' star Kate Walsh shares 'very subtle' warning signs ahead of brain tumor diagnosis
"Grey's Anatomy" star Kate Walsh is opening up about a health scare she faced years ago.
During a recent appearance on "The Kelly Clarkson Show," the 57-year-old actress recalled being diagnosed with a noncancerous brain tumor in 2015 and shared how the experience changed her approach to health.
"Thankfully, it turned out to be benign, so I was very, very fortunate," Walsh said.
The "Private Practice" alum explained she noticed "very subtle" warning signs ahead of her diagnosis.
"It was like, 'Hey, I'm really tired,'" Walsh recalled. "And then it's like, 'Oh, the right side of my body is dipping.'"
Walsh told Clarkson she was uncertain if she had a health problem at the time, since people around her were initially dismissive of her concerns.
"They're like, 'Oh, you're off.' I'm like, 'No,'" she said. "And then, walking the dog, I'm like, 'It must be a little bit of a windy street.'
"It was just sort of very subtle and then very kind of, 'Oh it's ADD. I can't really focus. Oh, I've been scrolling too much.' That kind of stuff."
Walsh continued to worry about her symptoms and decided to seek medical attention.
Looking back, the California native shared that she learned a valuable lesson from the experience.
"I know how important it is to advocate for one's own health because people were like, 'You're just depressed.' It was right after [my TV show] 'Bad Judge' got canceled,'" Walsh recalled.
"Your show got canceled. You're just depressed,'" she remembered people telling her. "I'm like, 'No, something's off.'"
Walsh first revealed her brain tumor diagnosis in a September 2017 interview with Cosmopolitan.
The "Emily in Paris" actress told the outlet she had physical and cognitive problems before doctors discovered a tumor in her brain the size of a small lemon. Walsh told the outlet she initially believed her symptoms were due to menopause, noting "there are a lot of the same markers."
"I know how important it is to advocate for one's own health because people were like, 'You're just depressed.'"
"I really pushed to see a neurologist. I just had an instinct," she recalled. "I had to really advocate because they don't hand out MRIs so easily. But I got an MRI and, thank God I did, because it turned out I had a very sizable brain tumor in my left frontal lobe."
Walsh told the outlet she was stunned after receiving her diagnosis.
"I just left my body," she said. "My assistant had driven me there, and I had to go get him so that he could take notes because I was gone. It was never anything I would have imagined."
Three days later, Walsh had surgery to remove the growth, and it was later determined to be a benign meningioma.
According to the Mayo Clinic, meningiomas are "brain tumors that start in the membranes around the brain and spinal cord" and they are the most common type of benign brain tumors.
While appearing on "The Kelly Clarkson Show," Walsh shared that she has a family history of cancer. Her father died due to complications from lung cancer, and her mother was a breast cancer survivor.
The actress emphasized the importance of early detection and screening but acknowledged that it can be difficult for people to speak out about their health concerns.
"It's a hard thing when you have everybody looking at you going, 'Hmm, I think you're just this or that. You're tired.'"
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
2 hours ago
- Medscape
Migraine Expert Renews Call for Prompt, Effective Management
OTTAWA — Therapies that target calcitonin gene-related peptide (CGRP) should be used up front in the treatment and prevention of migraine because of their efficacy, safety, and potential to modify the disease course, an expert said. Speaking at the annual meeting of the Canadian Neurological Sciences Federation (CNSF) Congress 2025, David Dodick, MD, emeritus professor of neurology at Mayo Clinic in Phoenix, reiterated the appeal that was first published in an American Headache Society position statement: That migraine therapies that target CGRP become first-line treatments for migraine. A Bold Call Some of the available monoclonal antibodies to treat migraine include erenumab, fremanezumab, galcanezumab, and eptinezumab. The class of 'gepants' includes rimegepant and atogepant. All these treatments target CGRP. 'This was a type of expert consensus opinion,' Dodick told Medscape Medical News , referring to the 'rather bold' position statement. 'The real-world evidence supports what we saw in clinical trials, and we now know the safety profile of these [therapies] because we've had them for almost 8 years of use in clinical practice. They are not first-line [therapies] simply because of cost.' The largest prospective study on the use of anti-CGRP monoclonal antibodies demonstrated robust responses to these therapies. Because CGRP-targeting therapies are well tolerated, discontinuation due to adverse events is generally not a concern, and increased efficacy may be realized if patients stay the course with CGRP-targeting therapies, said Dodick. 'You can imagine that if people are able to tolerate them and stay on these drugs longer, then efficacy is cumulative over time. Adherence and compliance increase the response rate over time,' said Dodick. Early Treatment Vital 'It really does matter how early you get to the patient and treat them effectively, both from the standpoint of treating an individual episode of migraine and from the prevention standpoint: That is, treating the disease earlier,' said Dodick. 'The more frequent that migraines are, and the more you allow them to be frequent, the more likely they are to progress to a daily migraine, and the more difficult they are to manage.' In the US and Canada, patients with migraine must first fail other treatments before they are prescribed newer agents like CGRP monoclonal antibodies or gepants, and this requirement creates the potential for a lapse in care, noted Dodick. 'Patients can become discouraged and lost to follow-up if they fail one medicine and then two medicines,' which he said supports the case for first-line access to CGRP-targeting migraine therapies. High-Impact Agents The efficacy of migraine treatments that target CGRP is convincing, said Michael Hill, MD, professor of clinical neuroscience at the University of Calgary's Cumming School of Medicine, Calgary. 'For some patients, they can get back to living a relatively normal life,' said Hill, who also is CNSF president. 'It can be a remarkable evolution. They go from being nonfunctioning and not working to being fully functional again because their migraine is not chronic, or their recurrent migraines are not so disabling.' Seeing patients who are unable to access these therapies is disheartening, Hill told Medscape Medical News. 'It is hard to see them denied this therapy.' The preventive potential that these therapies could offer would certainly be welcome, Hill added. 'The idea that some of these people who start with simple migraine and progress to a chronic, refractory migraine state, and that these might actually be preventable with early treatment, is really exciting.' Episodic treatment of migraine has not altered the disease course. 'The focus on migraine therapy has been on acute treatment and not so much on this idea that you might prevent the evolving chronicity of the disease.'
Business Insider
14 hours ago
- Business Insider
Medical equipment repair is a fast-growing healthcare career. The average salary is $65,000, and it doesn't require a 4-year degree.
Healthcare technology management, or HTM, is a growing field with promising career opportunities — but it's one that remains under the radar. It ranked 22nd in the US News & World Report's list of the 100 best jobs of 2025. And according to a report from the US Bureau of Labor Statistics, jobs in medical equipment repair are expected to grow by 18% between 2023 and 2033 — a faster rate than average for all occupations. Several factors are driving this growth. Medical equipment repairers or biomedical equipment technicians are an increasingly vital part of the healthcare ecosystem. They maintain, calibrate, and repair everything from vital-sign monitors to MRIs. "You can't deliver healthcare without either a patient, a provider, or an instrument," Jinesh Patel, the founder and CEO of the medical equipment management company UptimeHealth, told Business Insider. "Without an X-ray, the radiologist isn't doing anything. Without a vitals monitor, the nurse can't tell you what's going on." The industry is also aging out faster than new BMETs can be trained. A survey from the Association for the Advancement of Medical Instrumentation found that about a third of HTM professionals are over 55. "A large portion of our experienced workforce is reaching retirement age, leaving a significant talent gap across the country," said Kristi McDermott, the chief operating officer of the clinical asset management company Trimedx. She added that too few people know about the viability, or even existence, of this profession. "There's going to be a vacuum of knowledge very soon," said Patel, who added that he regularly struggles to find enough technicians for his hiring needs. The US Bureau of Labor Statistics projects 7,300 openings for medical equipment repairers each year over the next decade; meanwhile, the Association for the Advancement of Medical Instrumentation reports that BMET programs only graduate about 400 students a year. "This is a huge labor demand that isn't being met, and this is the time, in my opinion, for anyone to get involved," Patel told BI. BMET careers are accessible, well-paid, and meaningful While many other high-growth healthcare jobs require advanced degrees, medical equipment repair is a career you can start more quickly and affordably. Many technicians enter the field with just an associate degree, meaning they have relatively minimal college debt, and earn an average entry-level salary of about $65,000 a year. "That's a high ROI on day one," Richard Gonzales, the president of the College of Biomedical Equipment Technology, said. Some jobs require even less prior education and training, as some employers offer paid apprenticeships or on-the-job training to meet skyrocketing demand. Gonzales said that his college is constantly working with top-tier healthcare organizations to help technicians land jobs faster. "These organizations all want the same thing — to reduce the time it takes to establish minimum competency for an entry-level technician — and they're willing to put in the sweat equity to support that individual's career path," he explained. Many BMETs are also inspired by the ability to have a real-world impact on people's lives. "You are actually helping create access to healthcare. Every time you get a machine back up and running, a patient can be seen on that machine again," Patel said. "If you're interested in pursuing a career that has real meaning, just look at the patient connected to the device — you're making a difference," Gonzales said. He added that he sees a lot of veterans, like himself, pursue this as a second career for just that reason: "You served your country, now you can serve your community." A future-proof trade for a modern healthcare system Patel likened medical equipment repair to trade careers like plumbing and electrician work: The need for those jobs isn't going away anytime soon. "There's no world, at least that we can perceive, that equipment will not be used to help facilitate healthcare," he said. "It's almost a guaranteed profession." Gonzales said the opportunities for career growth are broad for technicians who are excited to continue learning. "When you think about innovation, medical device integration, cybersecurity, network medical devices, advances in patient care, and AI," he said, "somebody is either designing and creating these devices, installing them, hooking them to patients, or maintaining and repairing them." Patel added that the industry is ripe for new people to come in and help shape its future: "If people get excited about not just doing a job, but being the next wave of leaders and people who help take it to the next level, this is the place to do it."
Yahoo
16 hours ago
- Yahoo
Psyllium husk is being touted as ‘nature's Ozempic' – here's what experts say
As Ozempic and similar GLP-1s have transformed the world of weight loss, health companies and influencers have been scrambling to find 'nature's Ozempic' – cheaper, non-prescription products they claim can help with weight loss. The latest buzzy supplement? Psyllium husk. 'Psyllium husk has become popular thanks to a wave of social media influencers and wellness personalities touting its ability to suppress appetite, regulate digestion and even mimic the effects of more costly medications,' says Lena Beal, spokesperson for the Academy of Nutrition and Dietetics. But comparing it to Ozempic is 'oversimplified and misleading', she warns. On TikTok, more than 12,500 videos boast the psyllium husk tag. But this substance is not new; it has long been popular in India and across south Asia. Is psyllium husk a miracle weight-loss substance? No. But there are benefits, experts say. The outer covering of any seed is called a husk. Psyllium husk comes from the seed of Plantago ovata plants, a type of shrub that grows in sandy deserts and steppes. In the US, 'it is best known as the active ingredient in over-the-counter laxatives like Metamucil', says Beal. Psyllium husk can be consumed in pill or powder form. It can also be consumed whole, when is resembles tiny wood shavings. When combined with water, it creates a gloopy, gel-like substance. That gloopiness may not sound appealing, but it's part of what makes the product useful. Psyllium husk is a good source of soluble fiber, explains Katherine Zeratsky, a registered dietitian at the Mayo Clinic in Minnesota. Soluble fiber – unlike insoluble fiber, which remains unchanged during digestion – attracts water during digestion and turns into a gel. This gel can soften stools and add bulk to them, which helps in the management of constipation and diarrhea, says Julia Zumpano, a registered dietitian with the Cleveland Clinic Center for Human Nutrition. Related: What is okra water and is it good for your health? Additionally, Zumpano says, this gel can bind with the bile in your gut, which is composed of cholesterol, and remove it with the body's waste, thus reducing the amount of cholesterol in your body. Beal points to a 2018 meta-analysis in the American Journal of Clinical Nutrition which found 10-15g of psyllium husk a day significantly reduced LDL (or 'bad' cholesterol) and total cholesterol in 'healthy individuals and those with high cholesterol'. By slowing the rate of glucose in the bloodstream, it can also help in blood sugar management, says Zumpano. Psyllium husk can also increase one's overall consumption of fiber, a significant benefit given that only 5% of people in the US and 9% of adults in the UK eat the recommended amount of 25-30g of fiber a day. Psyllium husk provides about 7g of fiber per tablespoon. Eating fiber in any form has many benefits, says Zumpano, including 'slowing down digestion and increasing satiety, which are both benefits of weight-loss drugs'. (She is careful to add that fiber does not accomplish either of these outcomes to the extent GLP-1s can.) When increasing your fiber intake, start slowly and adjust as necessary, says Zeratsky. She suggests starting with a powder form, which gives you control of the amount. Experts emphasize that it's extremely important to consume psyllium husk with enough water: roughly 500ml of water per 20g of fiber. Because psyllium husk expands quickly with liquid, without an adequate amount of water, it can become a choking hazard and potentially lead to gastrointestinal obstruction, says Beal. This also means it may not be ideal for everyone. 'People with swallowing difficulties, bowel strictures or severe gastrointestinal conditions like Crohn's disease should consult a healthcare provider before using psyllium,' says Beal. Fiber and psyllium can also potentially interact with certain medications, warns Zeratsky, so consult a doctor or pharmacist before taking it. Also, thinking of it as 'nature's Ozempic' comes with its own risks, experts say. Overconsumption can lead to digestive discomfort, she warns, adding that people may overly rely on a single ingredient instead of a 'holistic lifestyle change'. If psyllium husk isn't your thing, there are plenty of other foods that offer similar benefits, says Zeratsky. 'Fruits, vegetables, beans and other legumes, and whole grains, particularly oats, barley and quinoa, all contain soluble fiber' and a variety of other beneficial nutrients, she says.
